Oncology
Video - COPERNICUS, a pragmatic phase 2b study of subcutaneous amivantamab plus chemotherapy with enhanced dermatologic adverse event prophylaxis in EGFR-mutated advanced NSCLC: Interim results
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.